Key Engineering Materials
Vol. 377
Vol. 377
Key Engineering Materials
Vols. 375-376
Vols. 375-376
Key Engineering Materials
Vols. 373-374
Vols. 373-374
Key Engineering Materials
Vols. 368-372
Vols. 368-372
Key Engineering Materials
Vol. 367
Vol. 367
Key Engineering Materials
Vols. 364-366
Vols. 364-366
Key Engineering Materials
Vols. 361-363
Vols. 361-363
Key Engineering Materials
Vols. 359-360
Vols. 359-360
Key Engineering Materials
Vols. 353-358
Vols. 353-358
Key Engineering Materials
Vol. 352
Vol. 352
Key Engineering Materials
Vol. 351
Vol. 351
Key Engineering Materials
Vol. 350
Vol. 350
Key Engineering Materials
Vols. 348-349
Vols. 348-349
Key Engineering Materials Vols. 361-363
Paper Title Page
Abstract: The association of TricOsTM (Macroporous Biphasic Ceramic Phosphate MBCP
granules) and the fibrin sealant FS VH S/D 4, has been developed to answer a challenging request
of orthopaedic surgeons: a biocompatible, osteogenic, mouldable, and self-hardening bone
substitute able to fill randomly shaped bone defects. The aims of this study was the evaluation of
the performance and safety of the bioactive bone substitute TricOs™ associated with a fibrin
sealant in regeneration of functional bone. The pre-clinical tests were conducted to optimize MBCP
granules size and ratio MBCP–FS VH S/D 4 (sheep maxillary sinus grafting, femoral epiphysis
defect in rabbits, long bone defects in sheep). A clinical study design was set up as an exploratory
prospective French multicentric phase II study sponsored by INSERM (Institut National de la Santé
et de la Recherche Médicale). The application was the TOV (Tibial Osteotomy of Valgisation)
using osteosynthesis and bone substitute: TricOs™ mixed with the fibrin sealant (FS VH S/D 4) for
filling the space created. The follow up is 13 months with safety checks, clinical assessments, highsensitivity
X-ray, and CT-scan imaging. A bone sample will be collected from the reconstructed
area at 12 months, during the osteosynthesis material removal surgery. The principal criterion is
CT-scan imaging performed 12 months after TOV surgery, before material removal, to assess
qualitative and quantitative bone reconstruction. Animals’ studies demonstrate that the biomaterial
is safe to use and shows osteoconductive properties, granules resorption and bone ingrowth at the
expenses of the implants. As for clinical trial, 7 patients are today included in the study: This paper
present the first results obtained from X-ray imaging during follow up.
1335
Abstract: To overcome autograft use for dental implantation, it is important to prevent bone loss
after tooth extraction or to restore alveolar bone level after pathological diseases. Biphasic calcium
phosphate (BCP), mixture of HA and ß-TCP, have proven its performance in orthopaedic, while
few studies have been reported in dentistry. We reported 5 years clinical follow up on bone
regeneration after immediate dental root filling. MBCP 60/40 and MBCP 20/80 are biphasic CaP
intimate mixture of HA/TCP 60/40 and 20/80; with interconnected macroporosity and
microporosity. Forty cases have been distributed in two groups for alveolar pocket filling. Seven
cases without filling are used as control. X-Ray at 0, 3, 6, 12 months and 5 years follow up for some
patients were performed. In all the 40 cases, radio-opacity of the implantation area decreases on
time, indicating resorption and bone ingrowths at the expense of the two bioceramics. No difference
in the resorption kinetics appeared on X-Ray. After 1 year, the implantation area looks as
physiological bone and is maintained on time. The newly formed bone is preserved after 5 years
contrarily to the controls cases (without filling)where we observed decrease of 2 to 5 mm. This
study demonstrated that immediate filling of alveolar pocket after tooth extraction is a preventive
method of the jaw bone resorption. After long term (other one year) resorption and bone ingrowth
were demonstrated for both micro and macroporous biphasic calcium phosphate with two different
HA/TCP ratio.
1339
Abstract: Successful craniofacial reconstruction needs both a well-known and a reliable
reconstruction material. However, there is often a lack of long-term knowledge of the tissue
reactions and healing process in the human body. In this study, frontal sinus obliterations with
bovine bone natural hydroxyapatite derivative (BHA), synthetic bioactive glass S53P4 (BAG) and
hydroxyapatite cement (HAC) were investigated with clinical, histologic, scanning electron
microscopic (SEM) and energy dispersive x-ray analysis (EDXA) 27, 12 and 3 years
postoperatively. The aim was to determine the long-term clinical biocompatibility of the used
materials. Histologic studies revealed bone formation with BHA particles and lamellar bone with
BAG granule remnants in close contact to the new bone formation. In HAC reconstruction there
was scattered fibroconnective tissue growth without new bone formation in the surface of HAC
implantation. Neither foreign body reaction nor any abnormal findings were seen. SEM studies
revealed a CaP layer on the surface of BAG granule remnants. In EDXA studies, composition
profiles showed Ca-, P- and Si- rich layers on the BAG granule surface. No differences were found
in CaO and P2O5 levels between BHA granules and HAC implantation and the surrounding bone.
All investigated biomaterials were well tolerated in long-term applications.
1343
Abstract: The development of implantology requires enough bone support, sufficient bone
architecture. The use of autograft remains the gold standard; however the surgeons use cortical bone
coming from mandibular part or craniofacial site, involving severe anaesthetic bone loss. The
strategy of bone substitutes in place of autograft can be an efficient method. Several patients having
a sinus lift augmentation using MBCP, and BioOss have been performed in human, and bone
biopsies were realized during the preparation of the site for dental implantation. Biopsies were
analyzed in classical histology without decalcification and by 3D reconstruction using micro CT.
Both techniques revealed bone ingrowth and MBCP resorption. For BioOss, no bone ingrtowth and
resorption process were observed in spite of stability of the implant and clinical efficiency. These
case reports confirm the performance of bone substitutes for Sinus Lift augmentation.
1347
Abstract: Surface roughness modulates the osseointegration of orthopaedic and dental titanium
implants. High surface roughness is currently obtained by blasting of titanium implants with silica
or aluminium abrasive particles. This process includes into the surface abrasive particles and may
cause the release of cytotoxic silica or aluminium ions in the peri implant tissue. To overcome this
drawback, we currently develop an innovative gridblasting process using Biphasic Calcium
Phosphate (BCP) particles (RBBM Resorbable and Biocompatible Blast Media) to generate
biocompatible roughened titanium surface.
This work present the technique of blasting using RBBM particles to provide a roughened surface
which does not release cytotoxic elements and (ii) to assess the effects of such a roughened surface
for bone osteointegration in critical size rabbit defect. Our results demonstrate that resorbable
biphasic calcium phosphate abrasive particles can be used to create titanium surface roughness. This
grid blasting process increases surface roughness of titanium implants and offers a non cytotoxic
surface for rapid and efficient osteointegration.
1351